Nutrigenomics and antioxidants

Personalized Medicine

Volumn 5, Issue 1, 2008, Pages 25-36

  Chalabi, Nasséra ^a,b   Bernard Gallon, Dominic J ^a,b   Vasson, Marie Paule ^a,c   Bignon, Yves Jean ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Antioxidant; Gene expression; Genomics; Nutrition

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BIOTIN; CAROTENOID; CYANOCOBALAMIN; CYSTEINE; FLAVONOID; FOLIC ACID; LYCOPENE; METHIONINE; NICOTINAMIDE; NICOTINIC ACID; PANTOTHENIC ACID; PHENOL DERIVATIVE; PLACEBO; POLYPHENOL DERIVATIVE; PYRIDOXINE; RESVERATROL; RETINOL; RIBOFLAVIN; SELENIUM; TANNIN DERIVATIVE; THIAMINE; UNINDEXED DRUG; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CANCER PREVENTION; CARCINOGENICITY; CATARACT; CELL METABOLISM; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG STRUCTURE; ESOPHAGUS CANCER; EYE DISEASE; GENE EXPRESSION; HUMAN; HYPERTENSION; LUNG CANCER; MONOTHERAPY; MUTAGENICITY; NEOPLASM; NONHUMAN; NUTRIGENOMICS; OXIDATIVE STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTECTION; REPEATED DRUG DOSE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STOMACH CANCER; VITAMIN SUPPLEMENTATION;

EID: 38049144699     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.5.1.25     Document Type: Review

References (79)

1. Vasson MP, Beaudeux J-L: Sources cellulaires des espèces réactives de l'oxygène. In: Radicaux libres et stress oxydant. Aspects biologiques et pathologiques. Beaudeux J-L, Delattre J, Bonnefont-Rousselot D (Eds). Editions Tec&Doc, Lavoisier, France 45-86 (2005).
2. Walrand S, Farges MC, Dehaese O et al.: In vivo and in vitro evidences that carotenoids could modulate the neutrophil respiratory burst during dietary manipulation. Eur. J. Nutr. 44(2), 114-120 (2005).
3. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER, Willett WC: Intake of carrots, spinach, and supplements containing vitamin A in relation to risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 6(11), 887-892 (1997).
4. Richer S, Stiles W, Statkute L et al.: Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75(4), 216-230 (2004).
5. Roje S: Vitamin B biosynthesis in plants. Phytochemistry 68(14), 1904-1921 (2007).
6. Tahiliani AG, Beinlich CJ: Pantothenic acid in health and disease. Vitam. Horm. 46, 165-228 (1991).
7. Ames BN: Micronutrient deficiencies. A major cause of DNA damage. Ann. NY Acad. Sci. 889, 87-106 (1999).
8. Friso S, Girelli D, Martinelli N et al.: Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am. J. Clin. Nutr. 79(6), 992-998 (2004).
9. Lin PT, Cheng CH, Liaw YP et al.: Low pyridoxal 5′-phosphate is associated with increased risk of coronary artery disease. Nutrition 22(11-12), 1146-1151 (2006).
10. Robinson K, Arheart K, Refsum H et al.: Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97(5), 437-443 (1998).
11. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N: Biochemistry of homocysteine in health and diseases. Indian J. Biochem. Biophys. 43(5), 275-283 (2006).
12. Takagi H, Umemoto T: Homocysteinemia is a risk factor for aortic dissection. Med. Hypotheses 64(5), 1007-1010 (2005).
13. Bsoul SA, Terezhalmy GT: Vitamin C in health and disease. J. Contemp. Dent. Pract. 5(2), 1-13 (2004).
14. Lee KW, Lee HJ, Surh YJ, Lee CY: Vitamin C and cancer chemoprevention: reappraisal. Am. J. Clin. Nutr. 78(6), 1074-1078 (2003).
15. Rock CL, Jacob RA, Bowen PE: Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J. Am. Diet Assoc. 96(7), 693-702; quiz 703-704 (1996).
16. Ness AR, Chee D, Elliott P: Vitamin C and blood pressure - an overview. J. Hum. Hypertens. 11(6), 343-350 (1997).
17. Snodderly DM: Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 62(6 Suppl.), 1448S-1461S (1995).
18. Taylor A, Jacques PF, Epstein EM: Relations among aging, antioxidant status, and cataract. Am. J. Clin. Nutr. 62(6 Suppl.), 1439S-1447S (1995).
19. Hickey S, Roberts H: Misleading information on the properties of vitamin C. PLoS Med. 2(9), e307; author reply e309 (2005).
20. Brigelius-Flohe R, Traber MG: Vitamin E: function and metabolism. Faseb J. 13(10), 1145-1155 (1999).
21. Kamal-Eldin A, Appelqvist LA: The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31(7), 671-701 (1996).
22. Rock E, Winklhofer-Roob BM, Ribalta J et al.: Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr. Metab. Cardiovasc. Dis. 11(4 Suppl.), 70-73 (2001).
23. Scheurig AC, Thorand B, Fischer B, Heier M, Koenig W: Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. Eur. J. Clin. Nutr. (2007) (Epub ahead of print).
24. Flohe L: Selenium, selenoproteins and vision. Dev. Ophthalmol. 38, 89-102 (2005).
25. Ahmad N, Gupta S, Mukhtar H: Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells. Arch. Biochem. Biophys. 376(2), 338-346 (2000).
26. Kuriyama S, Shimazu T, Ohmori K et al.: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296(10), 1255-1265 (2006).
27. Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ: Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 49(5), 462-471 (2005).
28. Baglietto L, English DR, Hopper JL, Powles J, Giles GG: Average volume of alcohol consumed, type of beverage, drinking pattern and the risk of death from all causes. Alcohol Alcohol. 41(6), 664-671 (2006).
29. Prasad AS: Zinc: mechanisms of host defense. J. Nutr. 137(5), 1345-1349 (2007).
30. Ho E: Zinc deficiency, DNA damage and cancer risk. J. Nutr. Biochem. 15(10), 572-578 (2004).
31. 2+ ions. J. Biol. Chem. 282(22), 16068-16078 (2007).
32. Hunt JR: Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am. J. Clin. Nutr. 78(3 Suppl.), 633S-639S (2003).
33. Papp LV, Lu J, Holmgren A, Khanna KK: From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid. Redox Signal. 9(7), 775-806 (2007).
34. Rayman MP: The importance of selenium to human health. Lancet 356(9225), 233-241 (2000).
35. Neve J: Selenium as a 'nutraceutical': how to conciliate physiological and supra-nutritional effects for an essential trace element. Curr. Opin. Clin. Nutr. Metab. Care 5(6), 659-663 (2002).
36. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330(15), 1029-1035 (1994).
37. Blot WJ, Li JY, Taylor PR et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl Cancer Inst. 85(18), 1483-1492 (1993).
38. Hercberg S, Galan P, Preziosi P et al.: The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 164(21), 2335-2342 (2004).
39. Smigel K: β-carotene fails to prevent cancer in two major studies; CARET intervention stopped. J. Natl Cancer Inst. 88(3-4), 145 (1996).
40. Riboli E, Hunt KJ, Slimani N et al.: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 5(6B), 1113-1124 (2002).
41. Agudo A, Slimani N, Ocke MC et al.: Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr. 5(6B), 1179-1196 (2002).
42. Slimani N, Fahey M, Welch AA et al.: Diversity of dietary patterns observed in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr. 5(6B), 1311-1128 (2002).
43. van Gils CH, Peeters PH, Bueno-de-Mesquita HB et al.: Consumption of vegetables and fruits and risk of breast cancer. JAMA 293(2), 183-193 (2005).
44. Linseisen J, Rohrmann S, Miller AB et al.: Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 121(5), 1103-1114 (2007).
45. Miller AB, Altenburg HP, Bueno-de-Mesquita B et al.: Fruits and vegetables and lung cancer: findings from the European Prospective Investigation into Cancer and Nutrition. Int. J. Cancer 108(2), 269-276 (2004).
46. Trujillo E, Davis C, Milner J: Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J. Am. Diet Assoc. 106(3), 403-413 (2006).
47. Kussmann M, Raymond F, Affolter M: OMICS-driven biomarker discovery in nutrition and health. J. Biotechnol. 124(4), 758-787 (2006).
48. Chalabi NL, Delort L, Le Corre L et al.: Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7(5), 663-672 (2006).
49. Chalabi N, Satih SL Delort L, Bignon YJ, Bernard-Gallon DJ: Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim. Biophys. Acta 1769(2), 124-130 (2007).
50. Siler U, Barella L, Spitzer V et al.: Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. Faseb J. 18(9), 1019-1021 (2004).
51. Afman L, Muller M: Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet Assoc. 106(4), 569-76 (2006).
52. Ordovas JM, Corella D: Nutritional genomics. Annu. Rev. Genomics Hum. Genet. 5, 71-118 (2004).
53. Hu N, Wang C, Hu Y et al.: Genome-wide association study in esophageal cancer using GeneChip mapping 10κ array. Cancer Res. 65(7), 2542-2546 (2005).
54. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res. 6(10), 986-994 (1996).
55. Chalabi N, Le Corre L, Maurizis JC, Bignon YJ, Bernard-Gallon DJ: The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur. J. Cancer 40(11), 1768-1775 (2004).
56. Fustier P, Le Corre L, Chalabi N et al.: Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumor cell lines. Br. J. Cancer 89(1), 168-172 (2003).
57. Le Corre L, Fustier P, Chalabi N, Bignon YJ, Bernard-Gallon DJ: Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin. Chim. Acta 344(1-2), 115-121 (2004).
58. Caetano B, Le Corre L, Chalabi N et al.: Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br. J. Nutr. 95(2), 406-413 (2006).
59. Vissac-Sabatier C, Bignon YJ, Bernard-Gallon DJ: Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr. Cancer 45(2), 247-255 (2003).
60. Vissac-Sabatier C, Coxam V, Dechelotte P et al.: Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res. 63(20), 6607-6612 (2003).
61. Campion J, Milagro FI, Martinez JA: Genetic manipulation in nutrition, metabolism, and obesity research. Nutr. Rev. 62(8), 321-330 (2004).
62. Ragozin S, Niemeier A, Laatsch A et al.: Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler. Thromb. Vasc. Biol. 25(7), 1433-1438 (2005).
63. Singh S, Chakravarti D, Edney JA et al.: Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol. Rep. 14(4), 1091-1096 (2005).
64. Cooney CA, Dave AA, Wolff GL: Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 132(8 Suppl.), 2393S-2400S (2002).
65. Stover PJ: Physiology of folate and vitamin B12 in health and disease. Nutr. Rev. 62(6 Pt 2), S3-S12; discussion S13 (2004).
66. Lee SC, Chan J, Clement MV, Pervaiz S: Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics 6(8), 2386-2394 (2006).
67. Weinreb O, Amit T, Youdim MB: A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic. Biol. Med. 43(4), 546-556 (2007).
68. Seeram NP, Adams LS, Zhang Y et al.: Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J. Agric. Food Chem. 54(25), 9329-9339 (2006).
69. Chalabi N, Maurizis JC, Le Corre L et al.: Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 821(2), 188-193 (2005).
70. Mutch DM, Grigorov M, Berger A et al.: An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet. Faseb J. 19(6), 599-601 (2005).
71. Khan SA, Priyamvada S, Arivarasu NA, Khan S, Yusufi AN: Influence of green tea on enzymes of carbohydrate metabolism, antioxidant defense, and plasma membrane in rat tissues. Nutrition 23(9), 687-695 (2007).
72. Kaput J, Rodriguez RL: Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genomics 16(2), 166-177 (2004).
73. Jain KK: Personalized medicine. Curr. Opin. Mol. Ther. 4(6), 548-558 (2002).
74. Schmith VD, Campbell DA, Sehgal S et al.: Pharmacogenetics and disease genetics of complex diseases. Cell. Mol. Life Sci. 60(8), 1636-1646 (2003).
75. Ghosh D, Skinner MA, Laing WA: Pharmacogenomics and nutrigenomics: synergies and differences. Eur. J. Clin.Nutr. 61(5), 567-574 (2007).
76. Nozaki Y, Kusuhara H, Endou H, Sugiyama Y: Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier. J. Pharmacol. Exp. Ther. 309(1), 226-234 (2004).
77. Sacco SM, Chen J, Power KA, Ward WE, Thompson LU: Lignan-rich sesame seed negates the tumor-inhibitory effect of tamoxifen but maintains bone health in a postmenopausal athymic mouse model with estrogen-responsive breast tumors. Menopause (2007) (Epub ahead of print).
78. Glinsky GV: Death-from-cancer signatures and stem cell contribution to metastatic cancer. Cell Cycle 4(9), 1171-1175 (2005).
79. Lehucher-Michel MP, Lesgards JF, Delubac O et al.: [Oxidative stress and human disease. Current knowledge and perspectives for prevention]. Presse Med. 30(21), 1076-1081 (2001).